This study aimed to examine the expression patterns of SDC1, SDC2, and SDC4 in EVs isolated from peripheral blood of neoadjuvant chemotherapy-naïve obese breast cancer patients with negative LNM (nLNM) and positive LNM (pLNM) to discover their potential as new biomarkers for LNM. Here, SDC4 is linked to breast cancer.